8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2008 / Before-and-after intervention study
Thirteen healthy female nurses participated in a 3-day/2-night forest bathing trip involving walking in forest fields. Blood and urine samples were collected before the trip, during the trip, and on days 7 and 30 post-trip. The trip significantly increased natural killer (NK) activity and numbers of NK cells, perforin, granulysin, and granzymes A/B-expressing cells, while significantly reducing the percentage of T cells and urinary adrenaline and noradrenaline levels. The elevated NK activity persisted for more than 7 days after the trip.
Li Q, Morimoto K, Kobayashi M, et al. J Biol Regul Homeost Agents, 2008. PMID 18394317
2008 / Randomized pilot trial
Thirty-six men and their partners were randomized to 11 dietary and cooking classes integrating mindfulness or to a wait-list control group. The intervention group demonstrated significant reductions in saturated fat consumption, increased intake of vegetable proteins, decreased intake of animal proteins including dairy, and increased quality of life. While no significant difference was found in the rate of PSA increase or log PSA slope between groups, the mean PSA doubling time was substantially longer in the intervention group compared with controls at 3-month follow-up.
Carmody J, Olendzki B, Reed G, et al. Urology, 2008. PMID 18400281
2008 / Uncontrolled pre-post trial (participants served as own controls)
Twenty-seven participants with oral intraepithelial neoplasia applied 0.5 g of a 10% freeze-dried black raspberry gel topically four times daily for 6 weeks, serving as their own internal controls. None of the 27 participants developed gel-associated toxicities. Results showed histologic regression in a subset of patients as well as a statistically significant reduction in loss of heterozygosity at tumor suppressor gene-associated loci.
Shumway BS, Kresty LA, Larsen PE, et al. Clin Cancer Res, 2008. PMID 18413833
2008 / Randomized controlled trial
In a randomized trial, 58 men at risk of or with low-grade prostate cancer consumed 40 g daily of isoflavone-rich soy protein, alcohol-washed soy protein, or milk protein for 6 months. Serum PSA and prostate tissue biomarkers did not change with isoflavone-rich soy protein, whereas Bax expression decreased with alcohol-washed soy. A significantly lower rate of prostate cancer was detected in the soy groups compared to the milk group (P = 0.01).
Hamilton-Reeves JM, Rebello SA, Thomas W, et al. Nutr Cancer, 2008. PMID 18444130
2008 / Open-label nonrandomized phase II trial
In an open-label, nonrandomized phase II trial, 20 patients with prostate-specific antigen recurrence after previous local therapy consumed soy milk containing 47 mg of isoflavones three times daily for 12 months. An estimated annual PSA increase of 56% before entry slowed to 20% during the trial (p = 0.05). Post-entry slope was significantly reduced in 6 patients, increased in 2 patients, and remained statistically unchanged in 12 patients.
Pendleton JM, Tan WW, Anai S, et al. BMC Cancer, 2008. PMID 18471323
2008 / Phase I non-randomized clinical trial
In a phase I dose-finding study, patients with advanced cancer received infusions of ascorbic acid ranging from 0.4 to 1.5 g/kg three times weekly. Toxicity and adverse events were minimal across all dose groups. However, no participant showed an objective anticancer response.
Hoffer LJ, Levine M, Assouline S, et al. Ann Oncol, 2008. PMID 18544557
2008 / Pre-post trial with baseline hemisected lesion biopsy
This study evaluated the effects of a 10% freeze-dried black raspberry gel applied topically (0.5 g four times daily for 6 weeks) to human oral intraepithelial neoplasia (IEN) lesions, using baseline hemisected biopsy samples as controls. Berry gel application uniformly suppressed genes linked to RNA processing, growth factor recycling, and apoptosis inhibition. Although most participants had posttreatment reductions in epithelial iNOS and COX-2 proteins, only the reductions in COX-2 reached statistical significance. In a subset of patients, berry gel application also reduced superficial connective tissue vascular densities and induced genes related to keratinocyte terminal differentiation.
Mallery SR, Zwick JC, Pei P, et al. Cancer Res, 2008. PMID 18559542
2008 / Pilot intervention study
A pilot study evaluated changes in prostate gene expression among men with low-risk prostate cancer undergoing active surveillance while participating in an intensive nutrition and lifestyle intervention. Significant improvements in weight, abdominal obesity, blood pressure, and lipid profiles were observed (all P < 0.05). Paired gene expression profiles from 30 participants revealed 48 up-regulated and 453 down-regulated transcripts after 3 months, with pathway analysis showing modulation of biological processes critical to tumorigenesis (P < 0.05).
Ornish D, Magbanua MJ, Weidner G, et al. Proc Natl Acad Sci U S A, 2008. PMID 18559852
2008 / Randomized controlled trial
A randomized trial followed 93 patients with early-stage prostate cancer on active surveillance for two years. Participants were assigned to usual care or a one-year program of a low-fat, plant-based diet, exercise, stress management, and support groups. By two years, 5% (2 of 43) of lifestyle participants had undergone conventional prostate cancer therapy versus 27% (13 of 49) of controls (P < .05). Untreated groups did not differ in PSA change or velocity.
Frattaroli J, Weidner G, Dnistrian AM, et al. Urology, 2008. PMID 18602144
2008 / Multicenter randomized, controlled, single-blinded clinical trial
A multicenter trial randomly assigned 1,277 peripheral arterial disease patients to iron reduction by phlebotomy (n = 636) or control (n = 641), followed for an average of 4.5 years. Risk of new visceral malignancy was lower in the iron reduction group compared to control (38 vs 60; HR = 0.65, 95% CI = 0.43 to 0.97; P = .036). Among patients who developed new cancers, those in the iron reduction group had lower cancer-specific mortality (HR = 0.39, 95% CI = 0.21 to 0.72; P = .003) and lower all-cause mortality (HR = 0.49, 95% CI = 0.29 to 0.83; P = .009).
Zacharski LR, Chow BK, Howes PS, et al. J Natl Cancer Inst, 2008. PMID 18612130
2008 / Phase II trial
Twenty-five patients with advanced pancreatic cancer received 8 g of oral curcumin daily until progression. Circulating conjugates peaked at 22 to 41 ng/mL, reflecting poor bioavailability. Two of 21 evaluable participants showed biological activity, including one individual with stable disease exceeding 18 months and another with a temporary 73% tumor reduction. Curcumin down-regulated peripheral mononuclear cell expression of NF-kappaB, COX-2, and pSTAT3 without causing toxicities.
Dhillon N, Aggarwal BB, Newman RA, et al. Clin Cancer Res, 2008. PMID 18628464
2008 / Pilot clinical trial
A pilot study evaluated 30 men with low-risk prostate cancer asked to adopt comprehensive lifestyle modifications for 3 months. In 24 participants with adequate samples, natural log-transformed telomerase activity was 2.00 at baseline and 2.22 after 3 months (p = 0.031). Increased telomerase activity correlated with lower LDL cholesterol (r = -0.36, p = 0.041) and less psychological distress (r = -0.35, p = 0.047).
Ornish D, Lin J, Daubenmier J, et al. Lancet Oncol, 2008. PMID 18799354
2008 / Phase I/II clinical trial
In this phase I/II trial, 20 patients with advanced malignancies receiving chemotherapy received a beta-(1,3)/(1,6) D-glucan formulation. Investigators monitored participants for tolerability and effects on blood cell production. The authors concluded that the fungal supplement was well-tolerated and may have a beneficial effect on hematopoiesis during chemotherapy.
Weitberg AB J Exp Clin Cancer Res, 2008. PMID 18803849
2008 / Comparative clinical trial
Researchers analyzed circulating markers from long-term human studies lasting 1 and 6 years. Severe calorie restriction with adequate nutrition did not change serum IGF-1 or the IGF-1 to IGFBP-3 ratio. In contrast, lowering protein intake from 1.67 to 0.95 g/kg/day for 3 weeks in six calorie-restricted volunteers reduced serum IGF-1 from 194 to 152 ng/mL.
Fontana L, Weiss EP, Villareal DT, et al. Aging Cell, 2008. PMID 18843793
2008 / Randomized controlled trial
Investigators randomly assigned 153 patients receiving remission induction therapy for acute myeloid leukemia in protected rooms to a cooked diet without raw produce (n=78) or a diet with fresh produce (n=75). Major infections developed in 29% of the cooked diet group and 35% of the raw diet group (P = .60). Time to major infection and survival were similar between groups, while fever of unknown origin occurred in 51% versus 36%.
Gardner A, Mattiuzzi G, Faderl S, et al. J Clin Oncol, 2008. PMID 18955453
2008 / Randomized controlled trial
In a randomized trial, patients who had colorectal adenomas removed and confirmed clean colon at 1 year were assigned to 1.5 g green tea extract daily (n=71) or no supplementation (n=65) for 12 months. Among the 125 patients completing follow-up colonoscopy, the incidence of metachronous adenomas was 15% (9 of 60) in the green tea extract group versus 31% (20 of 65) in controls (relative risk, 0.49; 95% CI, 0.24-0.99; P < 0.05). Relapsed adenoma size was also significantly smaller in the supplemented group (P < 0.001), with no serious adverse events reported.
Shimizu M, Fukutomi Y, Ninomiya M, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 18990744
2008 / Multisite randomized controlled trial
Prostate cancer patients (n = 161) awaiting surgery were randomly assigned to a usual diet control, flaxseed supplementation (30 g/d), a low-fat diet (<20% energy), or a combined flaxseed and low-fat diet for an average of 30 days. Proliferation rates (Ki-67) were significantly lower (P < 0.002) in men in the flaxseed arms, with median Ki-67-positive ratios of 1.66 (flaxseed) and 1.50 (flaxseed + low-fat) compared to 3.23 (control) and 2.56 (low-fat). No significant differences between arms were observed for side effects, apoptosis, or most serologic endpoints, though low-fat diets significantly decreased serum cholesterol (P = 0.048).
Demark-Wahnefried W, Polascik TJ, George SL, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 19064574
2008 / Randomized controlled primary prevention trial
In the Women's Health Initiative Dietary Modification trial, 48,835 postmenopausal women were randomized to a dietary modification intervention (aiming for 20% energy from fat, >=5 servings/d fruits/vegetables, and >=6 servings/d grains) or a comparison group. Over an average follow-up of 7.7 years, 570 incident cases of benign proliferative breast disease occurred in the intervention group and 793 in the comparison group. The hazard ratio comparing the intervention group to the comparison group was 1.09 (95% CI, 0.98-1.23). The intervention resulted in smaller than targeted changes in practice, and risk varied by baseline total vitamin D intake.
Rohan TE, Negassa A, Caan B, et al. Cancer Prev Res (Phila), 2008. PMID 19138971
2008 / Phase II randomized controlled trial
Forty-five men with clinically localized prostate cancer were randomized to receive 15, 30, or 45 mg of lycopene or no supplement from biopsy to prostatectomy (approximately 30 days). Plasma lycopene increased in all treatment groups, with the greatest increase in the 45 mg arm compared to controls, without producing toxicity. Serum free testosterone decreased with 30 mg lycopene, and total estradiol increased significantly with 30 mg and 45 mg from baseline to post-treatment, with no significant increases in serum PSA or tissue Ki-67. However, these changes were not statistically significant compared to the control group for the study's sample size and duration.
Kumar NB, Besterman-Dahan K, Kang L, et al. Clin Med Urol, 2008. PMID 20354574
2007 / Prospective clinical trial
Researchers evaluated the in vivo effects of daily oral 1-3, 1-6, D-beta glucan given for 15 days to 23 women with advanced breast cancer. Mean monocyte counts increased significantly from 326/mm3 to 496/mm3 (p=0.015). CD14-positive monocyte expression of CD95 rose from 48.17% to 69.23% (p=0.002) and CD45RA expression rose from 49.9% to 61.52% (p=0.001).
Demir G, Klein HO, Mandel-Molinas N, et al. Int Immunopharmacol, 2007. PMID 17161824
2007 / Interventional pilot study (before-and-after)
Ten non-smoking Jordanian volunteers (5 men and 5 women) consumed a standard diet of 500 g of broccoli for 6 days, followed by caffeine testing on day 7 to measure CYP1A2 and CYP2A6 activities via urinary metabolite ratios. Following broccoli consumption, mean CYP1A2 activity significantly increased from 21.1+/-3.2 to 52.5+/-6.6 in men and from 27.6+/-1.6 to 36.6+/-8.4 in women (P<0.005). Mean CYP2A6 activity also significantly increased from 0.061+/-0.040 to 0.193+/-0.02 in men and from 0.144+/-0.039 to 0.214+/-0.064 in women (P<0.05).
Hakooz N, Hamdan I Curr Drug Metab, 2007. PMID 17266520
2007 / Phase I dose escalation pharmacokinetic study
A phase I study evaluated single oral doses of resveratrol (0.5, 1, 2.5, or 5 g) in 10 healthy volunteers per dose level. Administration did not cause serious adverse events. Peak plasma levels of resveratrol at the 5 g dose were 539 +/- 384 ng/mL (2.4 micromol/L), occurring 1.5 hours post-dose, while peak levels of metabolites were 3- to 8-fold higher. The authors note that because in vitro cancer chemopreventive effects require at least 5 micromol/L, high-dose resveratrol might be insufficient to elicit systemic levels commensurate with efficacy, though conjugate metabolites warrant investigation.
Boocock DJ, Faust GE, Patel KR, et al. Cancer Epidemiol Biomarkers Prev, 2007. PMID 17548692
2007 / Randomized controlled trial
Researchers evaluated dietary intakes of total protein and soy isoflavones in relation to the IGF axis in prostate cancer patients participating in the Prostate Cancer Lifestyle Trial, which included a very low-fat vegan diet supplemented with 58 g/day of soy protein versus usual care. After one year, the intervention group reported significantly higher intakes of dietary protein and soy isoflavones than controls (P < 0.001). IGF-1 increased significantly in both groups, while IGFBP-1 rose in the experimental group only (P < 0.01). Increases in vegetable protein over one year were associated with increases in IGFBP-1 among intervention patients (P < 0.05).
Dewell A, Weidner G, Sumner MD, et al. Nutr Cancer, 2007. PMID 17571965
2007 / Randomized controlled trial
In a randomized trial of 3,088 women previously treated for early-stage breast cancer, an intensive telephone-counseling intervention promoted high vegetable, fruit, and fiber intake alongside low dietary fat. Over an average of 7.3 years of follow-up, invasive events occurred in 16.7% of intervention participants versus 16.9% of controls (adjusted HR, 0.96; 95% CI, 0.80-1.14). All-cause mortality was also similar between groups, reaching 10.1% versus 10.3% (adjusted HR, 0.91; 95% CI, 0.72-1.15).
Pierce JP, Natarajan L, Caan BJ, et al. JAMA, 2007. PMID 17635889